Paper3182103
Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer.
Zurawski VR and 3 others. Int J Cancer, 1988. Cited by 205 papers, by iCite.
Cite this record
ConductScience Library. Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer. Papers, record 3182103. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3182103
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Tumor-Associated, Carbohydrate | Major topic |
| Ovarian Neoplasms | Major topic |
| Adult | |
| Blood Banks | |
| Female | |
| Humans | |
| Middle Aged | |
| Retrospective Studies |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 1 R43 CA 40945-01 | NCI NIH HHS | United States | R43CA409450 | PubMed | NIH RePORTER |
| 1 R44 CA 40945-02 | NCI NIH HHS | United States | R44CA409450 | PubMed | NIH RePORTER |
| R43CA040945 | NIH | NIH RePORTER | |||
| R44CA040945 | NIH | NIH RePORTER |
Cited by51
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 205 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40783897 | High-density lectin microarray uncovers stage-specific plasma glycoprofiling signatures for non-muscle-invasive and muscle-invasive bladder cancer. | Int Urol Nephrol | 2026 | https://conductscience.org/library/papers/40783897 | PubMed |
| 40071681 | Tumor Glycosylation: A Main Player in the Modulation of Immune Responses. | Eur J Immunol | 2025 | https://conductscience.org/library/papers/40071681 | PubMed |
| 39587891 | Diagnostic value and application prospect of tumor abnormal protein test in head and neck tumors. | Sci Prog | 2024 | https://conductscience.org/library/papers/39587891 | PubMed |
| 39098853 | Glycosylation: mechanisms, biological functions and clinical implications. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39098853 | PubMed |
| 38910518 | Recent advances in N-glycan biomarker discovery among human diseases. | Acta Biochim Biophys Sin (Shanghai) | 2024 | https://conductscience.org/library/papers/38910518 | PubMed |
| 38861100 | Glycosylation editing: an innovative therapeutic opportunity in precision oncology. | Mol Cell Biochem | 2025 | https://conductscience.org/library/papers/38861100 | PubMed |
| 38384845 | The transcriptional landscape of glycosylation-related genes in cancer. | iScience | 2024 | https://conductscience.org/library/papers/38384845 | PubMed |
| 37958700 | Top-Down Proteomics of Human Saliva, Analyzed with Logistic Regression and Machine Learning Methods, Reveal Molecular Signatures of Ovarian Cancer. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37958700 | PubMed |
| 37455827 | Capitalizing glycomic changes for improved biomarker-based cancer diagnostics. | Explor Target Antitumor Ther | 2023 | https://conductscience.org/library/papers/37455827 | PubMed |
| 37082219 | New trends in diagnosing and treating ovarian cancer using nanotechnology. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/37082219 | PubMed |
| 36338982 | Identification of a prognostic risk-scoring model and risk signatures based on glycosylation-associated cluster in breast cancer. | Front Genet | 2022 | https://conductscience.org/library/papers/36338982 | PubMed |
| 36037117 | Ovarian Cancer-Self Assessment: An Innovation for Early Detection and Risk Assessment of Ovarian Cancer. | Asian Pac J Cancer Prev | 2022 | https://conductscience.org/library/papers/36037117 | PubMed |
| 35797639 | High-Throughput Glycomic Methods. | Chem Rev | 2022 | https://conductscience.org/library/papers/35797639 | PubMed |
| 35740550 | Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35740550 | PubMed |
| 35159077 | Diagnostic Performance of Risk of Malignancy Algorithm (ROMA), Risk of Malignancy Index (RMI) and Expert Ultrasound Assessment in a Pelvic Mass Classified as Inconclusive by International Ovarian Tumour Analysis (IOTA) Simple Rules. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35159077 | PubMed |
| 34495529 | Mucin-Type O-GalNAc Glycosylation in Health and Disease. | Adv Exp Med Biol | 2021 | https://conductscience.org/library/papers/34495529 | PubMed |
| 34093804 | Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer. | J Cancer | 2021 | https://conductscience.org/library/papers/34093804 | PubMed |
| 33302373 | Insights into Bioinformatic Applications for Glycosylation: Instigating an Awakening towards Applying Glycoinformatic Resources for Cancer Diagnosis and Therapy. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33302373 | PubMed |
| 31717613 | Ovarian Cancer Targeting Phage for In Vivo Near-Infrared Optical Imaging. | Diagnostics (Basel) | 2019 | https://conductscience.org/library/papers/31717613 | PubMed |
| 31428516 | High-throughput assessment of the antibody profile in ovarian cancer ascitic fluids. | Oncoimmunology | 2019 | https://conductscience.org/library/papers/31428516 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MUC16 | 94025 | PubTator's text mining | https://conductscience.org/library/genes/94025 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3182103
GET https://conductscience.org/api/papers/v1/3182103/cited_by?page=2